Evolution: Poor eyesight reveals a new vision gene
Comparing the genomes of mammals which evolved to have poor vision identifies an important gene for eyesight.
- Stowers Institute for Medical Research, United States
- Department of Molecular and Integrative Physiology, University of Kansas Medical Center, United States
With hundreds of cell types smoothly working together to form clear images of the world, the vertebrate eye can put the most sophisticated digital cameras to shame. Yet many of the genes which establish and maintain this delicate machine remain unknown.
Most mammals have good vision, yet some species have naturally evolved poor eyesight: mice and rats, for instance, have very poor eyesight, while species like the naked mole rat have lost their vision entirely. One way to identify the genetic sequences important for vision is to compare the genomes of species with contrasting visual capacities. Now, in eLife, Michael Hiller (Senckenberg Research Institute), Michael Brand (TU Dresden) and colleagues – including Henrike Indrischek (Max Planck Institute for Molecular Cell Biology and Genetics) as first author – report that a largely uncharacterized gene called Serpine3 is inactivated in many animals with poor or compromised vision, suggesting it may play an important role in the eye (Indrischek et al., 2022).
First, the team screened the genomes of 49 mammalian species for mutations associated with a severe loss in eye function. This sample included ten species which had poor visual capacity, such as rodents, moles and echolocating bats. A gene was classified as playing a role in eyesight if mutations stopped it from working in more than three species with poor vision. This led to the identification of 29 genes, 15 of which had not been linked to eye development or function before. However, poor vision is mostly restricted to mammals living in low-light habitats which are often limited in nutrients and biodiversity (Olsen et al., 2021). As such, the loss-of-function mutations detected by Indrischek et al. may be unrelated to vision and instead be the result of animals adapting to these challenging environments.
Indrischek et al. then focused on one gene, Serpine3, which was predicted to be inactive in seven out of the ten low-vision species (Figure 1). Conversely, animals with excellent vision, such as elephants and chimpanzees, have intact Serpine3 coding regions (Figure 1). To strengthen their hypothesis, Indrischek et al. added 381 other species with varying visual capabilities to their analysis. Out of the 430 species studied, 70 with poor eyesight had inactivated Serpine3.
Figure 1
Mutations in Serpine3 are associated with vision loss.
To identify genes that shape the eyes of vertebrates, Indrischek et al. screened the genome of mammals with poor (left, red) and good (right, green) vision. Most animals with poor eyesight – such as cape-golden moles, bats and naked mole rats – had mutations in the gene Serpine3 which led to its inactivation. However, in mammals with better vision – such as elephants, humans and chimpanzees – the coding region for Serpine3 was intact and the gene was active. Further experiments confirmed that the product of the Serpine3 gene is important for good vision.
The product of the Serpine3 gene belongs to a family of proteins secreted into the extracellular space and implicated in blood clotting, neuroprotection and some human diseases (Law et al., 2006; Barnstable and Tombran-Tink, 2004). To better understand the role Serpine3 plays in vision, the team carried out functional experiments in zebrafish, as their retinas are organized into layers which are similar to those found in humans (Fadool, 2003). This showed that Serpine3 is highly expressed in the zebrafish eye, particularly in the inner nuclear layer of the retina. Next, Indrischek et al. deleted Serpine3 during zebrafish development, causing adult animals to have deformed eyes and disrupting the organization of the cell layers in the retina. This suggests that vertebrate eyes need the product of Serpine3 in order to function properly.
Finally, Indrischek et al. analyzed a human dataset of genomic sequences from patients with eye-related diseases. They found mutations near to the transcription start site for Serpine3 are associated with refractive errors in the eye and macular degeneration, suggesting that this gene may also play a role in human eye diseases.
Taken together, these findings suggest that Serpine3 is important for good vision. In the future, it would be interesting to explore whether the gene is primarily important during development, or to maintain retinal cells and layers during adulthood. This knowledge could help identify new therapies for debilitating eye diseases associated with Serpine3 or other related genes.
More importantly, Indrischek et al. elegantly demonstrate how studying natural variation in traits such as eyesight can identify the function of uncharacterized genes and the role they may play in disease. Nature is full of characteristics which converged between species over the course of evolution (Farhat et al., 2013; Bergmann and Morinaga, 2019). Applying a comparative genomic approach similar to the one used in this study could transform our understanding of a multitude of other biological processes (Liu et al., 2021; Valenzano et al., 2015; Rohner, 2018). We just have to look.
References
-
Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potentialProgress in Retinal and Eye Research 23:561–577.https://doi.org/10.1016/j.preteyeres.2004.05.002
-
The convergent evolution of snake-like forms by divergent evolutionary pathways in squamate reptilesEvolution; International Journal of Organic Evolution 73:481–496.https://doi.org/10.1111/evo.13651
-
Development of a rod photoreceptor mosaic revealed in transgenic zebrafishDevelopmental Biology 258:277–290.https://doi.org/10.1016/s0012-1606(03)00125-8
-
Lipid metabolism in adaptation to extreme nutritional challengesDevelopmental Cell 56:1417–1429.https://doi.org/10.1016/j.devcel.2021.02.024
-
Cavefish as an evolutionary mutant model system for human diseaseDevelopmental Biology 441:355–357.https://doi.org/10.1016/j.ydbio.2018.04.013
Article and author information
Author details
Publication history
Copyright
© 2022, Biswas, Krishnan et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,156
- views
-
- 163
- downloads
-
- 2
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Evolution: Poor eyesight reveals a new vision gene
eLife 11:e81520.
https://doi.org/10.7554/eLife.81520
Further reading
-
- Evolutionary Biology
With the availability of high-quality full genome polymorphism (SNPs) data, it becomes feasible to study the past demographic and selective history of populations in exquisite detail. However, such inferences still suffer from a lack of statistical resolution for recent, for example bottlenecks, events, and/or for populations with small nucleotide diversity. Additional heritable (epi)genetic markers, such as indels, transposable elements, microsatellites, or cytosine methylation, may provide further, yet untapped, information on the recent past population history. We extend the Sequential Markovian Coalescent (SMC) framework to jointly use SNPs and other hyper-mutable markers. We are able to (1) improve the accuracy of demographic inference in recent times, (2) uncover past demographic events hidden to SNP-based inference methods, and (3) infer the hyper-mutable marker mutation rates under a finite site model. As a proof of principle, we focus on demographic inference in Arabidopsis thaliana using DNA methylation diversity data from 10 European natural accessions. We demonstrate that segregating single methylated polymorphisms (SMPs) satisfy the modeling assumptions of the SMC framework, while differentially methylated regions (DMRs) are not suitable as their length exceeds that of the genomic distance between two recombination events. Combining SNPs and SMPs while accounting for site- and region-level epimutation processes, we provide new estimates of the glacial age bottleneck and post-glacial population expansion of the European A. thaliana population. Our SMC framework readily accounts for a wide range of heritable genomic markers, thus paving the way for next-generation inference of evolutionary history by combining information from several genetic and epigenetic markers.
-
- Computational and Systems Biology
- Evolutionary Biology
There is growing interest in designing multidrug therapies that leverage tradeoffs to combat resistance. Tradeoffs are common in evolution and occur when, for example, resistance to one drug results in sensitivity to another. Major questions remain about the extent to which tradeoffs are reliable, specifically, whether the mutants that provide resistance to a given drug all suffer similar tradeoffs. This question is difficult because the drug-resistant mutants observed in the clinic, and even those evolved in controlled laboratory settings, are often biased towards those that provide large fitness benefits. Thus, the mutations (and mechanisms) that provide drug resistance may be more diverse than current data suggests. Here, we perform evolution experiments utilizing lineage-tracking to capture a fuller spectrum of mutations that give yeast cells a fitness advantage in fluconazole, a common antifungal drug. We then quantify fitness tradeoffs for each of 774 evolved mutants across 12 environments, finding these mutants group into classes with characteristically different tradeoffs. Their unique tradeoffs may imply that each group of mutants affects fitness through different underlying mechanisms. Some of the groupings we find are surprising. For example, we find some mutants that resist single drugs do not resist their combination, while others do. And some mutants to the same gene have different tradeoffs than others. These findings, on one hand, demonstrate the difficulty in relying on consistent or intuitive tradeoffs when designing multidrug treatments. On the other hand, by demonstrating that hundreds of adaptive mutations can be reduced to a few groups with characteristic tradeoffs, our findings may yet empower multidrug strategies that leverage tradeoffs to combat resistance. More generally speaking, by grouping mutants that likely affect fitness through similar underlying mechanisms, our work guides efforts to map the phenotypic effects of mutation.
